Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Choy

Showing results (51-60 of 180) with videos related to

Pageof 18
Sort By:
Cancer Letters|September 7, 2013
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsBin Jia, Edwin Choy, Gregory Cote, et al.
Scientific Reports|April 30, 2016
Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitroJacson K Shen, Gregory M Cote, Yan Gao, et al.
The American Journal of Surgical Pathology|November 1, 2018
Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic DifferentiationAbhijit Chougule, Martin S Taylor, Valentina Nardi, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cellsCao Yang, Edwin Choy, Francis J Hornicek, et al.
Anticancer Research|April 22, 2011
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell linesCao Yang, Edwin Choy, Francis J Hornicek, et al.
Pharmaceutical Research|December 18, 2014
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian CancerXiaoqian Yang, Arun K Iyer, Amit Singh, et al.
Cancer Letters|February 11, 2010
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan, Diana Ji, Edward J Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2010
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo, Jeffrey Nemeth, Colin O'Brien, et al.
Oncotarget|November 12, 2016
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistanceTang Liu, Zhihong Li, Qing Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Pageof 18

Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Cancer Letters|September 7, 2013
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cellsBin Jia, Edwin Choy, Gregory Cote, et al.
Scientific Reports|April 30, 2016
Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitroJacson K Shen, Gregory M Cote, Yan Gao, et al.
The American Journal of Surgical Pathology|November 1, 2018
Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic DifferentiationAbhijit Chougule, Martin S Taylor, Valentina Nardi, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cellsCao Yang, Edwin Choy, Francis J Hornicek, et al.
Anticancer Research|April 22, 2011
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell linesCao Yang, Edwin Choy, Francis J Hornicek, et al.
Pharmaceutical Research|December 18, 2014
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian CancerXiaoqian Yang, Arun K Iyer, Amit Singh, et al.
Cancer Letters|February 11, 2010
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan, Diana Ji, Edward J Weinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2010
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo, Jeffrey Nemeth, Colin O'Brien, et al.
Oncotarget|November 12, 2016
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistanceTang Liu, Zhihong Li, Qing Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Pageof 18